Jenburkt Pharmaceuticals has informed that the information received from shareholder regarding loss of share certificate received on today, 13th December, 2023, is enclosed. This is in the process of issuing Letter of Confirmation, after compliance of required formalities.
The above information is a part of company’s filings submitted to BSE.